- Visibility 164 Views
- Downloads 69 Downloads
Spectrum of papillary lesions of breast with immunohistochemistry and review of literature
- Author Details:
-
Rupali Bavikar
-
Sanjay Deshmukh
-
Tejal Khande
Background: Papillary lesions of breast are very rare. They are classified as benign, borderline and malignant. Benign papillary lesions constitute less than 10% of all benign lesions of the breast and malignant papillary are less than 1% of all malignancies of breast. All papillary lesions appear similar on histopathology but they behave differently.
Objective: To differentiate the papillary lesions of breast with help of Immunohistochemisry (IHC) markers like P63, CK5/6, CD10 and SMA.
Material and Methods: This is retrospective study over a period of 5 years. We have done all above markers on histopathologically diagnosed cases of papillary lesions of breast.
Results: Out of 41, benign papillomas were 23 and invasive papillary carcinomas were 8, 5 cases were atypical papilloma and 5 were intracystic papillary carcinoma. The age group of patients was between 21 to 75 years with median age 40years. Lump in the breast was commonest presenting complaint.P63 was the most sensitive markers with minimum cross reactivity.
Conclusion: P63, CK5/6, CD10 and SMA can be used to differentiate between papillary lesions of the breast .P63 is more sensitive among all.
References
- Tavassoli FA. Papillary lesions. In: Pathology of the Breast. 2nd ed. New York, NY: McGraw-Hill; 1999:325-
- Tse GM, Tan PH, Lui PC, et al. The role of immunohistochemistry for smmoth muscle actin, p63, CD 10, and cytokeratin 14 in the differential diagnosis of papillary lesions of breast. Pathol Int 2007;60:315-320.
- Ichihara S, Fujimto T, Hashimoto K, et al. Double immunostaining with p63 and high molecular weight cytokeratins distinguishing borderline papillary lesions of the breast. Pathol Int 2007;57:126-32.
- Tan PH, Aw MY, Yip G, et al. Cytokeratins in papillary lesions of breast: Is there a role in distinguishing intrauctal papilloma from papillary ductal carcinoma insitu? Am J Surg Pathol 1996:20:921-943.
- Rabban JT, Koerner FC, Lerwill MF. Solid papillary ductal carcinoma insitu versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Hum Pathol 2006;37:787-93.
- Lacroix-Triki M, Mery E, Voigt JJ, et al. Value of cytokeratin 5/6 immunostaining using D 5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34 βE 12 antibody. Virchows Arch.
- Rosen PP. Papillary carcinoma. In: Rosen’s Breast Pathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:381-4048.
- Otterbach F, B`ankfalvi A, Bergner S, et al. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 2000;37:232–40.
- Tan PH, Aw MY, Yip G, et al. Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol 2005;29:625–32. Rupali Bavikar et al. Spectrum of papillary lesions of breast with immunohistochemistry and review…. Indian Journal of Pathology and Oncology, January-March 2017;4(1):52-55 55
- Rabban JT, Koerner FC, Lerwill MF. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Hum Pathol 2006;37:787–93.
- Lacroix-Triki M, Mery E, Voigt JJ, et al. Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34 beta E12 antibody. Virchows Arch 2003;442:548–54.
How to Cite This Article
Vancouver
Bavikar R, Deshmukh S, Khande T. Spectrum of papillary lesions of breast with immunohistochemistry and review of literature [Internet]. Indian J Pathol Oncol. 2017 [cited 2025 Oct 28];4(1):52-55. Available from: https://doi.org/
APA
Bavikar, R., Deshmukh, S., Khande, T. (2017). Spectrum of papillary lesions of breast with immunohistochemistry and review of literature. Indian J Pathol Oncol, 4(1), 52-55. https://doi.org/
MLA
Bavikar, Rupali, Deshmukh, Sanjay, Khande, Tejal. "Spectrum of papillary lesions of breast with immunohistochemistry and review of literature." Indian J Pathol Oncol, vol. 4, no. 1, 2017, pp. 52-55. https://doi.org/
Chicago
Bavikar, R., Deshmukh, S., Khande, T.. "Spectrum of papillary lesions of breast with immunohistochemistry and review of literature." Indian J Pathol Oncol 4, no. 1 (2017): 52-55. https://doi.org/